Inside EU Health

Inside EU Health: Tobacco control; EU/US trade deal; clinical trials; CEPI; scaleup fund

Europe is backslking on tobacco control; EU-US ‘Turnberry’ trade deal back on track; EU first report charting progress on its clinical trials ambitions; EU commits €73.7 million CEPI 100-day mission; EQT selected to manage EU Scaleup Europe Fund

Inside EU Health

Inside EU Health: WAITing; Ebola; tobacco consultation; UK/US pharma deal

WAITing for medicines; WHO releases further $3.4 million for Ebola outbreak; Commission launches consultation on tobacco regulation; NGOs challenge UK-US medicines pricing deal

Most Favored Nation

NGOs challenge UK-US medicines pricing deal

NGOs accuse the British government of trading NHS pricing safeguards for export protection, as Washington intensifies efforts to push higher medicine costs across Europe

Inside EU Health

Inside EU Health: Ebola update; nicotine pouches; biosecurity; WHA; hantavirus

Ebola declared emergency of international concern; WHO warns nicotine pouches risk hooking a new generation;  EuropaBio ups efforts on biosecurity; World Health Assembly kicks off; EU activates crisis response mechanism to monitor hantavirus outbreak

Ebola

DRC faces fresh Ebola outbreak in remote region

Health authorities in the Democratic Republic of the Congo are racing to contain a new Ebola outbreak

Novel nicotine products

WHO warns nicotine pouches risk hooking a new generation

The World Health Organization warns that use of nicotine pouches is expanding rapidly worldwide, with weak regulation leaving young people exposed to aggressive marketing and addiction

Hantavirus

EU activates crisis response mechanism to monitor hantavirus outbreak

The Cyprus Presidency has activated the EU’s crisis coordination mechanism to strengthen information sharing on the hantavirus outbreak

Inside EU Health

Inside EU Health: Global Health Resilience Initiative; critical medicines act; social media restrictions

‘Global Health Resilience Initiative’ disappoints; EU seals deal on Critical Medicines Act after marathon talks; EU could propose social media age restrictions as early as the summer

Critical Medicines Act

EU seals deal on Critical Medicines Act after marathon talks

After 12 hours of overnight negotiations, EU lawmakers reached a provisional agreement on the Critical Medicines Act aimed at boosting Europe’s pharmaceutical resilience

Inside EU Health

Inside EU Health: Critical Medicines Act; Hantavirus ship; Várhelyi cleared

Cypriots compromise to seal critical medicines deal; Hantavirus ship disembarks in Tenerife; Várhelyi cleared in Commission spying investigation

Inside EU Health

Inside EU Health: Critical Medicines Act; Urban Wastewater Treatment; novel nicotine; hantavirus update

Várhelyi says critical medicines deal possible as early as next week; Várhelyi ‘partner for any solution’ on Urban Wastewater Treatment Directive; novel nicotine products will be treated like cigarettes; latest WHO briefing on hantavirus

Hantavirus

Hantavirus confirmed as rare human-to-human variant

Laboratory testing by South African and Swiss reference laboratories identified the virus as Andes hantavirus — the only known hantavirus capable of person-to-person transmission

Inside EU Health

Inside EU Health: First EU joint clinical assessment; Hantavirus; protecting healthcare in conflict zones; disability

First EU joint clinical assessment is a milestone; Hantavirus poses little risk to wider public; international organisations mark failure to protect health care in conflict zones; disabled people face disproportionate discrimination in public services

Hantavirus

Cruise ship Hantavirus outbreak poses little risk to wider public

Cruise ship Hantavirus outbreak leaves three dead as WHO steps into action

Inside EU Health

Inside EU Health: Pandemic agreement delayed; OECD puts a price on poor mental health; Epi+ preparedness; mpox

‘Last piece of the puzzle’ in the WHO pandemic agreement delayed to 2027; OECD puts €76 billion price tag on the poor mental health in the EU;  Epi+ live will go live in June 2027; ECDC launch monthly mpox surveillance report

Pandemic Agreement

‘Last piece of the puzzle’ in the WHO pandemic agreement delayed to 2027

WHO member states agree to further negotiations to reach an agreement on key Pathogen Access and Benefit Shifting (PABS) annex

Inside EU Health

Inside EU Health: EMA vaccine confidence group; limits on vapes; liver health crisis

EMA steps up vaccine misinformation fight; Europe’s liver health crisis demands urgent action

Inside EU Health

Inside EU Health: EMA pilot for 'breakthrough' medical devices; snus; future budget

EMA pilot to fast-track breakthrough medical devices; Snus’s generational impact on asthma and allergies; MEPs adopt position on EU’s long-term budget reinforcing health measures

Nicotine alternatives

Snus’s generational impact on asthma and allergies

A study finds teenage snus use in boys is linked to higher asthma and bronchitis risk in their future children

Medical devices

EMA pilot to fast-track breakthrough medical devices

The European Medicines Agency has launched a new pilot programme aimed at accelerating the development of “breakthrough” medical devices

Inside EU Health

Inside EU Health: Medicines for Europe appeals court decision; pharmaceutical exports support 926,000 EU jobs

Generic makers appeal to fix tax on treatment; pharmaceutical exports supported 926 000 EU jobs

Urban Wastewater Treatment Directive

Generic makers appeal to fix tax on treatment

Medicines for Europe to appeal the decision on its challenge to Urban Wastewater Treatment Directive

Inside EU Health

Inside EU Health: UK Biobank suspended; France chooses ‘sovereign’ cloud for health data; latest EMA medicines approvals

UK Biobank suspends access following Alibaba revelations; France chooses ‘sovereign’ cloud for health data; EMA recommends five new medicines, including a first-in-class small interfering RNA treatment

UK Biobank

UK Biobank suspends access following Alibaba revelations

UK Biobank promises to carry out comprehensive and forensic board-led investigation

EMA

EMA recommends five new medicines, including a first-in-class small interfering RNA treatment

Five new medicines are recommended for approval; a further nine medicines are recommended for extension of their therapeutic indications